4//SEC Filing
Nuechterlein Carole 4
Accession 0001610717-23-000210
CIK 0001799448other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 4:10 PM ET
Size
5.2 KB
Accession
0001610717-23-000210
Insider Transaction Report
Form 4
Nuechterlein Carole
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-07-20+20,000→ 20,000 totalExercise: $1.00Exp: 2033-07-20→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2024 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date.
Documents
Issuer
Aligos Therapeutics, Inc.
CIK 0001799448
Entity typeother
Related Parties
1- filerCIK 0001665133
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 4:10 PM ET
- Size
- 5.2 KB